AstroNova (ALOT) just opened Q1 2027 with revenue of US$39.4 million and basic EPS of US$0.09, while trailing 12 month figures show a loss of US$1.3 million on basic EPS of US$0.18 loss. Over recent quarters the company has seen revenue move in a tight band between US$36.1 million and US$39.4 million, with quarterly EPS swinging between a loss of US$0.16 and a profit of US$0.09. This keeps the focus squarely on how efficiently that top line is being converted into profit. With the stock trading at US$15.58 and the business still loss making over the past year, this set of results puts margin resilience and the path to sustainable profitability at the center of the story.

See our full analysis for AstroNova.

With the headline numbers on the table, the next step is to stack these results against the dominant narratives around AstroNova to see which long running views on growth, profitability, and risk still hold up and which are being put to the test.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Q1 profit of US$0.7m versus prior losses

• AstroNova reported Q1 2027 net income of US$0.7 million, compared with a Q4 2026 loss of US$1.1 million and a Q2 2026 loss of US$1.2 million, while the trailing 12 month figures still show a net loss of US$1.3 million.
• Bears point to the trailing 12 month loss and a reported 55.8% annualized decline in earnings over five years, yet the recent quarter shows pockets of resilience:
  • Across the last five reported quarters, net income swung from a loss of US$15.6 million in Q4 2025 to modest profits of US$0.4 million in Q3 2026 and US$0.7 million in Q1 2027. This sits against a trailing 12 month loss of US$1.3 million.
  • This pattern of alternating small profits and losses means the bearish focus on long run earnings decline is still grounded in the data, even though individual quarters, like Q1 2027, occasionally show AstroNova in the black.

US$152.2m sales but still loss making

• Over the trailing 12 months to Q1 2027, AstroNova generated US$152.2 million of revenue but recorded a net loss of US$1.3 million and a basic EPS loss of US$0.18.
• Critics highlight that turning this revenue base into consistent profit is the key issue, and the numbers support that concern:
  • Quarterly revenue has stayed in a band between US$36.1 million and US$39.4 million over the last six reported quarters, yet net income over the same stretch ranged from a loss of US$15.6 million to a profit of US$0.7 million, underscoring how sensitive profit is to costs and one off items.
  • The five year view in the analysis data shows earnings declining at 55.8% per year, which lines up with the trailing 12 month loss and shows that stable sales alone have not been enough to support a durable earnings base.

To see how other investors are stitching these mixed signals into a bigger story around AstroNova, check out the Curious how numbers become stories that shape markets? Explore Community Narratives.

Low 0.8x P/S versus peers but above DCF fair value

• AstroNova trades on a P/S of 0.8x compared with 6.8x for peers and 2.9x for the US Tech industry, while the current share price of US$15.58 sits above the DCF fair value of US$9.83 indicated in the analysis.
• What stands out for valuation focused investors is the tension between a low sales multiple and the cash flow based figure:
  • The 0.8x P/S suggests the stock is priced below many direct comparables on revenue, even though the company is still unprofitable over the last 12 months with a US$1.3 million loss.
  • The DCF fair value of US$9.83, which is below the current US$15.58 share price, together with weak interest coverage flagged in the risk summary, reinforces the cautious view that low P/S alone does not offset the profitability and financing pressures in the current data.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on AstroNova's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

If this mix of profit pockets and trailing losses feels unclear, move quickly to review the underlying data and risks yourself. Before you firm up your own view on AstroNova, make sure you understand the 2 important warning signs.

See What Else Is Out There

AstroNova is still wrestling with trailing losses, volatile earnings, and weak interest coverage, which together raise questions about resilience if conditions become more challenging.

If you want stocks where financial stability is front and center instead of fragile margins and risk warnings, start comparing companies in the 63 resilient stocks with low risk scores today.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.